Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-002049

Options or other derivatives

  • Director acquired 4,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ratcliffe Liam Director 2019-01-02 Grant or award · Stock Option (Right to Buy) +4,860 $2.70 $13,122 4,860 D
Loading xslF345X03/doc4.xml…